Log in to save to my catalogue

Olanzapine-induced hyperphagia and weight gain associate with orexigenic hypothalamic neuropeptide s...

Olanzapine-induced hyperphagia and weight gain associate with orexigenic hypothalamic neuropeptide s...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1304772517

Olanzapine-induced hyperphagia and weight gain associate with orexigenic hypothalamic neuropeptide signaling without concomitant AMPK phosphorylation

About this item

Full title

Olanzapine-induced hyperphagia and weight gain associate with orexigenic hypothalamic neuropeptide signaling without concomitant AMPK phosphorylation

Publisher

United States: Public Library of Science

Journal title

PloS one, 2011-06, Vol.6 (6), p.e20571

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

Subjects

Subjects and topics

More information

Scope and Contents

Contents

The success of antipsychotic drug treatment in patients with schizophrenia is limited by the propensity of these drugs to induce hyperphagia, weight gain and other metabolic disturbances, particularly evident for olanzapine and clozapine. However, the molecular mechanisms involved in antipsychotic-induced hyperphagia remain unclear. Here, we invest...

Alternative Titles

Full title

Olanzapine-induced hyperphagia and weight gain associate with orexigenic hypothalamic neuropeptide signaling without concomitant AMPK phosphorylation

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_1304772517

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1304772517

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0020571

How to access this item